Dried blood as an alternative to plasma or serum for Trypanosoma cruzi IgG detection in screening programs

Clinical and Vaccine Immunology

Volumn 20, Issue 8, 2013, Pages 1197-1202

  Holguín, Africa ^a   Norman, Francesca ^a   Martín, Leticia ^a   Mateos, María Luisa ^a   Chacón, Jesús ^a   López Vélez, Rogelio ^a   Pérez Molina, José A ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PARASITE ANTIBODY;

ADULT; ANALYZER; ANTIBODY DETECTION; ANTIBODY SCREENING; ARTICLE; BLOOD SAMPLING; CHAGAS DISEASE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; SPAIN; TRYPANOSOMA CRUZI;

ADULT; ANTIBODIES, PROTOZOAN; BLOOD; CHAGAS DISEASE; DESICCATION; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MASS SCREENING; MIDDLE AGED; PARASITOLOGY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPAIN; SPECIMEN HANDLING; TRYPANOSOMA CRUZI;

EID: 84880881373     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00221-13     Document Type: Article

References (37)

1. Rassi A, Jr Rassi A, Marin-Neto JA. 2010. Chagas disease. Lancet 375: 1388-1402.
2. Perez-Molina JA, Norman F, Lopez-Velez R. 2012. Chagas disease in non-endemic countries: epidemiology, clinical presentation and treatment. Curr. Infect. Dis. Rep. 14:263-274.
3. Organización Panamericana de la salud (OPS/OMS). 2006. Estimación cuantitativa de la Enfermedad de Chagas en las Américas. OPS/HDM/CD/425-06. Montevideo, Uruguay.
4. Oliveira I, Torrico F, Munoz J, Gascon J. 2010. Congenital transmission of Chagas disease: a clinical approach. Expert Rev. Anti Infect. Ther. 8:945-956.
5. WHO.2010. Control and prevention of Chagas disease in Europe: report of a WHO Informal Consultation (jointly organized by WHO headquarters and the WHO Regional Office for Europe), Geneva, Switzerland, 17-18 December 2009. WHO, Geneva, Switzerland. http://www.fac.org.ar/1/comites/chagas/Chagas-WHO- Technical%20Report-16-06-10.pdf.
6. Basile L, Jansá J, Carlier Y, Salamanca D, Angheben A, Bartoloni A, Seixas J, Van Gool T, Canavate C, Flores-Chavez M, Jackson Y, Chiodini P, Albajar-Vinas P. 2011. Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill. 16:pii 19968. www.eurosurveillance.org/ ViewArticle.aspx?ArticleId-19968.
7. Flores-Chavez M, De Fuentes I, Gárate T, Cañavate C. 2007. Diagnóstico de laboratorio de la enfermedad de Chagas importada. Enferm. Infecc. Microbiol. Clin. 25(Suppl 3):29 -37.
8. Brasil PE, DeCastro L, Hasslocher-Moreno AM, Sangenis LH, Braga JU. 2010. ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis. BMC Infect. Dis. 10:337.
9. Chappuis F, Mauris A, Holst M, Albajar-Vinas P, Jannin J, Luquetti AO, Jackson Y. 2010. Validation of a rapid immunochromatographic assay for diagnosis of Trypanosoma cruzi infection among Latin- American Migrants in Geneva, Switzerland. J. Clin. Microbiol. 48:2948- 2952.
10. Lopez-Chejade P, Roca C, Posada E, Pinazo MJ, Gascon J, Portus M. 2010. Utility of an immunochromatographic test for Chagas disease screening in primary healthcare. Enferm. Infecc. Microbiol. Clin. 28:169- 171. (In Spanish.).
11. Navarro M, Perez-Ayala A, Guionnet A, Perez-Molina JA, Navaza B, Estevez L, Norman F, Flores-Chavez M, Lopez-Velez R. 2011. Targeted screening and health education for Chagas disease tailored to at-risk migrants in Spain, 2007 to 2010. Euro Surveill. 16:pii 19973. http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId-19973.
12. Prince PJ, Matsuda KC, Retter M, Scott G. 2010. Assessment of DBS technology for the detection of therapeutic antibodies. Bioanalysis 2:1449-1460.
13. Praast G, Herzogenrath J, Bernhardt S, Christ H, Sickinger E. 2011. Evaluation of the Abbott ARCHITECT Chagas prototype assay. Diagn. Microbiol. Infect. Dis. 69:74-81.
14. Flores-Chavez M, Cruz I, Rodriguez M, Nieto J, Franco E, Garate T, Canavate C. 2010. Comparison of conventional and non-conventional serological tests for the diagnosis of imported Chagas disease in Spain. Enferm. Infecc. Microbiol. Clin. 28:284-293. (In Spanish.).
15. Perez-Ayala A, Perez-Molina JA, Norman F, Navarro M, Monge-Maillo B, Diaz-Menendez M, Peris-Garcia J, Flores M, Canavate C, Lopez- Velez R. 2011. Chagas disease in Latin American migrants: a Spanish challenge. Clin. Microbiol. Infect. 17:1108-1113.
16. Rodriguez-Perez MA, Danis-Lozano R, Rodriguez MH, Bradley JE. 1999. Application of an enzyme-linked immunosorbent assay to detect antibodies to Onchocerca volvulus on filter-paper blood spots: effect of storage and temperature on antibody decay. Trans. R. Soc. Trop. Med. Hyg. 93:523-524.
17. Castro AC, Borges LG, Souza Rda S, Grudzinski M, D'Azevedo PA. 2008. Evaluation of the human immunodeficiency virus type 1 and 2 antibodies detection in dried whole blood spots (DBS) samples. Rev. Inst. Med. Trop. Sao Paulo. 50:151-156.
18. DeMulder M, Holguín A. 2013. Dried blood spots for monitoring HIV infection in Public Health Programs in developing countries. Enferm. Infecc. Microbiol. Clin. 31:100-107. (In Spanish.).
19. Dowd JB, Aiello AE, Chyu L, Huang YY, McDade TW. 2011. Cytomegalovirus antibodies in dried blood spots: a minimally invasive method for assessing stress, immune function, and aging. Immun. Ageing 8:3.
20. Hope VD, Hickman M, Ngui SL, Jones S, Telfer M, Bizzarri M, Ncube F, Parry JV. 2011. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. J. Viral Hepat. 18:262-270.
21. Melgaco JG, Pinto MA, Rocha AM, Freire M, Gaspar LP, Lima SM, Cruz OG, Vitral CL. 2011. The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination. J. Med. Virol. 83:208-217.
22. Hogrefe WR, Ernst C, Su X. 2002. Efficiency of reconstitution of immunoglobulin g from blood specimens dried on filter paper and utility in herpes simplex virus type-specific serology screening. Clin. Diagn. Lab. Immunol. 9:1338-1342.
23. Zicker F, Smith PG, Luquetti AO, Oliveira OS. 1990. Mass screening for Trypanosoma cruzi infections using the immunofluorescence, ELISA and haemagglutination tests on serum samples and on blood eluates from filter-paper. Bull. World Health Organ. 68:465-471.
24. Contreras MC, Salinas P, Sandoval L, Solís F, Rojas A. 1992. Usefulness of the ELISA-IgG test in sera and filter paper blood eluates in the Chagas disease immunodiagnosis. Bol. Chil. Parasitol. 47:76 - 81. (In Spanish.).
25. Palacios X, Belli A, Espino AM. 2000. Detection of antibodies against Trypanosoma cruzi in Somoto, Nicaragua, using indirect ELISA and IFI on blood samples on filter paper. Rev. Panam. Salud Pública 8:411-417. (In Spanish.).
26. Neto EC, Rubin R, Schulte J, Giugliani R. 2004. Newborn screening for congenital infectious diseases. Emerg. Infect. Dis. 10:1068-1073.
27. Segura EL, Escobar-Mesa A; Grupo de Estudio sobre la Enfermedad de Chagas. 2005. Epidemiology of Chagas disease in the state of Veracruz. Salud Pública Mex. 47:201-208. (In Spanish.).
28. Escribà JM, Ponce E, Romero Ade D, Viñas PA, Marchiol A, Bassets G, Palma PP, Lima MA, Zúniga C, Ponce C. 2009. Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras. Mem. Inst. Oswaldo Cruz 104: 986 -991.
29. Frade AF, Luquetti AO, Prata A, Ferreira AW. 2011. Western blotting method (TESAcruzi) as a supplemental test for confirming the presence of anti-Trypanosoma cruzi antibodies in finger prick blood samples from children aged 0-5 years in Brazil. Acta Trop. 117:10-13.
30. Ramos JM, Ponce Y, Gallegos I, Flóres-Chávez M, Cañavate C, Gutiérrez F. 2012. Trypanosoma cruzi infection in Elche (Spain): comparison of the seroprevalence in immigrants from Paraguay and Bolivia. Pathog. Glob. Health 106:102-106.
31. Parker SP, Cubitt WD. 1999. The use of the dried blood spot sample in epidemiological studies. J. Clin. Pathol. 52:633-639.
32. Weil GJ, Curtis KC, Fischer PU, Won KY, Lammie PJ, Joseph H, Melrose WD, Brattig NW. 2011. A multicenter evaluation of a new antibody test kit for lymphatic filariasis employing recombinant Brugia malayi antigen Bm-14. Acta Trop. 120(Suppl 1):S19 -S22.
33. Joseph HM, Melrose W. 2010. Applicability of the filter paper technique for detection of antifilarial IgG(4) antibodies using the Bm14 filariasis CELISA. J. Parasitol. Res. pii:594687. doi:10.1155/2010/594687.
34. Iborra-Bendicho MA, Albert-Hernández M, Márquez-Contreras C, Segovia- Hernández M. 2012. ARCHITECT Chagas(®): a new diagnostic tool in Chagas disease. Enferm. Infecc. Microbiol. Clin. 30:463-465. (In Spanish.).
35. Muñoz J, Coll O, Juncosa T, Verges M, del Pino M, Fumado V, Bosch J, Posada EJ, Hernandez S, Fisa R, Boguna JM, Gallego M, Sanz S, Portus M, Gascon J. 2009. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin. Infect. Dis. 48:1736- 1740.
36. Angheben A, Anselmi M, Gobbi F, Marocco S, Monteiro G, Buonfrate D, Tais S, Talamo M, Zavarise G, Strohmeyer M, Bartalesi F, Mantella A, Di Tommaso M, Aiello K, Veneruso G, Graziani G, Ferrari M, Spreafico I, Bonifacio E, Gaiera G, Lanzafame M, Mascarello M, Cancrini G, Albajar-Vinas P, Bisoffi Z, Bartoloni A. 2011. Chagas disease in Italy: breaking an epidemiological silence. Euro Surveill. 16:pii-19969. http://www.eurosurveillance.org/ViewArticle.aspx? ArticleId-19969.
37. Lescure FX, Paris L, Elghouzzi MH, LeLoup G, Develoux M, Touafek F, Mazier D, Pialoux G. 2009. Experience of targeted screening of Chagas disease in Ile-de-France. Bull. Soc. Pathol. Exot. 102: 295-299. (In French.).